{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:23:25Z","timestamp":1786375405841,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cpet.2023.02.009","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T15:45:19Z","timestamp":1680795919000},"page":"337-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fibroblast Activation Protein Inhibitor PET\/CT in Gastric Cancer"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-2395","authenticated-orcid":false,"given":"Tadashi","family":"Watabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik L.","family":"Giesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpet.2023.02.009_bib1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","article-title":"Cancer-associated fibroblasts in gastrointestinal cancer","volume":"16","author":"Kobayashi","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cpet.2023.02.009_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry estimate of 2 DOTA-containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.009_bib3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2967\/jnumed.119.227967","article-title":"68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer","volume":"60","author":"Kratochwil","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.009_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.009_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2967\/jnumed.120.245084","article-title":"FAPI-74 PET\/CT using either 18F-AlF or cold-kit 68Ga labeling: biodistribution, radiation dosimetry, and tumor delineation in lung cancer patients","volume":"62","author":"Giesel","year":"2021","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.009_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s41181-021-00142-z","article-title":"One-pot and one-step automated radio-synthesis of [18F]AlF-FAPI-74 using a multi purpose synthesizer: a proof-of-concept experiment","volume":"6","author":"Naka","year":"2021","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"4","key":"10.1016\/j.cpet.2023.02.009_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/s00259-015-3211-6","article-title":"Incremental diagnostic utility of gastric distension FDG PET\/CT","volume":"43","author":"Le Roux","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2023.02.009_bib8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/MNM.0000000000001481","article-title":"18F-FDG PET and PET\/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review","volume":"42","author":"Dondi","year":"2021","journal-title":"Nucl Med Commun"},{"issue":"1","key":"10.1016\/j.cpet.2023.02.009_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1756-9966-29-66","article-title":"Cancer-associated fibroblasts are positively correlated with metastatic potential of human gastric cancers","volume":"29","author":"Zhi","year":"2010","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.cpet.2023.02.009_bib10","doi-asserted-by":"crossref","first-page":"859999","DOI":"10.3389\/fcell.2022.859999","article-title":"Fibroblast activation protein-alpha is a prognostic biomarker associated with ferroptosis in stomach adenocarcinoma","volume":"10","author":"Lyu","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.cpet.2023.02.009_bib11","unstructured":"The human protein atlas, Available at: https:\/\/www.proteinatlas.org\/ENSG00000078098-FAP\/pathology. Accessed March 18, 2023."},{"key":"10.1016\/j.cpet.2023.02.009_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1148\/radiol.2020203275","article-title":"Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers","volume":"298","author":"Pang","year":"2021","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.cpet.2023.02.009_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnumed.120.258467","article-title":"68Ga-DOTA-FAPI-04 PET\/MR in the evaluation of gastric carcinomas: comparison with 18F-FDG PET\/CT","volume":"63","author":"Qin","year":"2022","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.009_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00259-021-05494-x","article-title":"Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma","volume":"49","author":"Kuten","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2023.02.009_bib15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s00259-021-05441-w","article-title":"Comparison of [68 Ga]Ga-FAPI-04 and [18F]-FDG for the detection of primary and metastatic lesions in patients with gastric cancer: a bicentric retrospective study","volume":"49","author":"Jiang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2023.02.009_bib16","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1007\/s00330-022-08743-1","article-title":"Superiority of [68Ga]Ga-FAPI-04\/[18F]FAPI-42 PET\/CT to [18F]FDG PET\/CT in delineating the primary tumor and peritoneal metastasis in initial gastric cancer","volume":"32","author":"Fu","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cpet.2023.02.009_bib17","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1007\/s00259-022-05799-5","article-title":"[68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT","volume":"49","author":"Lin","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.cpet.2023.02.009_bib18","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00330-022-09084-9","article-title":"Comparison of [68Ga]Ga-FAPI and [18F]FDG uptake in patients with gastric signet-ring-cell carcinoma: a multicenter retrospective study","volume":"33","author":"Chen","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cpet.2023.02.009_bib19","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2967\/jnumed.121.262808","article-title":"Pitfalls and common findings in 68Ga-FAPI PET: a pictorial analysis","volume":"63","author":"Kessler","year":"2022","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.009_bib20","first-page":"20220463","article-title":"Non-oncologic incidental uptake on FAPI PET\/CT imaging","author":"Hotta","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cpet.2023.02.009_bib21","doi-asserted-by":"crossref","unstructured":"Watabe T, Naka S, Tatsumi M. et al. Initial evaluation of [18F]FAPI-74 PET for various histopathologically confirmed cancers and benign lesions. J Nucl Med. 2023 (in press).","DOI":"10.2967\/jnumed.123.265486"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859823000226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859823000226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:11:52Z","timestamp":1761563512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859823000226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1556859823000226"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2023.02.009","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast Activation Protein Inhibitor PET\/CT in Gastric Cancer","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2023.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}